BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32161617)

  • 1. Effect of Tumor Location on Clinicopathological and Molecular Markers in Colorectal Cancer in Eastern China Patients: An Analysis of 2,356 Cases.
    Song Y; Wang L; Ran W; Li G; Xiao Y; Wang X; Zhang L; Xing X
    Front Genet; 2020; 11():96. PubMed ID: 32161617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and molecular differences between right-sided and left-sided colorectal cancer in Japanese patients.
    Natsume S; Yamaguchi T; Takao M; Iijima T; Wakaume R; Takahashi K; Matsumoto H; Nakano D; Horiguchi SI; Koizumi K; Miyaki M
    Jpn J Clin Oncol; 2018 Jul; 48(7):609-618. PubMed ID: 29767751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of clinicopathological features and prognosis of sporadic synchronous multiple primary colorectal cancers].
    Qin ZF; Xu GH; Zhou SQ; Zheng PW; Zhu YP; Ju HX; Li DC; Ma DN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1171-1178. PubMed ID: 38110279
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidemiological and clinicopathological features of KRAS, NRAS, BRAF mutations and MSI in Chinese patients with stage I-III colorectal cancer.
    Wang W; Wang R; Han X; Zhang W; Zhu L; Gu Y
    Medicine (Baltimore); 2024 Apr; 103(14):e37693. PubMed ID: 38579072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and molecular differences in colorectal cancer according to location.
    Hsu YL; Lin CC; Jiang JK; Lin HH; Lan YT; Wang HS; Yang SH; Chen WS; Lin TC; Lin JK; Lin PC; Chang SC
    Int J Biol Markers; 2019 Mar; 34(1):47-53. PubMed ID: 30854932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between mismatch repair protein,
    Fan JZ; Wang GF; Cheng XB; Dong ZH; Chen X; Deng YJ; Song X
    World J Clin Cases; 2021 Apr; 9(11):2458-2468. PubMed ID: 33889611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between genetic alterations and prognosis in sporadic colorectal cancer.
    Chang SC; Lin JK; Yang SH; Wang HS; Li AF; Chi CW
    Int J Cancer; 2006 Apr; 118(7):1721-7. PubMed ID: 16231316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer.
    Tanaka H; Deng G; Matsuzaki K; Kakar S; Kim GE; Miura S; Sleisenger MH; Kim YS
    Int J Cancer; 2006 Jun; 118(11):2765-71. PubMed ID: 16381005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between microsatellite instability and RAS gene mutation and stage III colorectal cancer.
    Niu W; Wang G; Feng J; Li Z; Li C; Shan B
    Oncol Lett; 2019 Jan; 17(1):332-338. PubMed ID: 30655771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
    Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
    Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF-Mutated Colorectal Cancer Exhibits Distinct Clinicopathological Features from Wild-Type BRAF-Expressing Cancer Independent of the Microsatellite Instability Status.
    Jang MH; Kim S; Hwang DY; Kim WY; Lim SD; Kim WS; Hwang TS; Han HS
    J Korean Med Sci; 2017 Jan; 32(1):38-46. PubMed ID: 27914130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
    Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
    Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between clinicopathological features and
    Zhu X; Meng X; Xiang W; Dai W; Bai Q; Sheng W; Lu Y; Qi P; Wu L; Cai G; Zhou X
    Int J Clin Exp Pathol; 2018; 11(5):2839-2845. PubMed ID: 31938404
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Zeng J; Fan W; Li J; Wu G; Wu H
    Int J Gen Med; 2023; 16():4109-4120. PubMed ID: 37720173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left-sided location is a risk factor for lymph node metastasis of T1 colorectal cancer: a single-center retrospective study.
    Mochizuki K; Kudo SE; Ichimasa K; Kouyama Y; Matsudaira S; Takashina Y; Maeda Y; Ishigaki T; Nakamura H; Toyoshima N; Mori Y; Misawa M; Ogata N; Kudo T; Hayashi T; Wakamura K; Sawada N; Ishida F; Miyachi H
    Int J Colorectal Dis; 2020 Oct; 35(10):1911-1919. PubMed ID: 32548720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of microsatellite instability and its substantial co-existence with
    Nguyen HT; Le DT; Duong QH; Tatipamula VB; Van Nguyen B
    Oncol Lett; 2021 Jan; 21(1):41. PubMed ID: 33262833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
    Zlobec I; Bihl MP; Schwarb H; Terracciano L; Lugli A
    Int J Cancer; 2010 Jul; 127(2):367-80. PubMed ID: 19908233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Microsatellite Instability Status and Sidedness of the Primary Tumor on the Effect of Cetuximab-Containing Chemotherapy in Patients with Metastatic Colorectal Cancer.
    Kim ST; Lee SJ; Lee J; Park SH; Park JO; Lim HY; Kang WK; Park YS
    J Cancer; 2017; 8(14):2809-2815. PubMed ID: 28928870
    [No Abstract]   [Full Text] [Related]  

  • 19. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B.
    Asaka S; Arai Y; Nishimura Y; Yamaguchi K; Ishikubo T; Yatsuoka T; Tanaka Y; Akagi K
    Carcinogenesis; 2009 Mar; 30(3):494-9. PubMed ID: 19147861
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Jin J; Shi Y; Zhang S; Yang S
    Acta Oncol; 2020 Jan; 59(1):66-74. PubMed ID: 31545109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.